Position in GSK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$312,376,808
-$18,679,634 QoQ
Shares Held
5,959,115
-0.7% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $148,142,177,604 across 19 Drug Manufacturers - General names. GSK ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
36,215,754 | $43,438,265,441 | |
| 2 | JNJ |
Johnson & Johnson
|
133,776,025 | $33,975,097,069 | |
| 3 | ABBV |
AbbVie Inc.
|
82,596,748 | $20,784,645,666 | |
| 4 | MRK |
Merck & Co., Inc.
|
120,413,256 | $15,473,103,396 | |
| 5 | AMGN |
Amgen Inc
|
30,560,537 | $11,066,581,658 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
61,216,552 | $7,734,099,179 | |
| 7 | PFE |
Pfizer Inc
|
307,090,897 | $7,394,748,799 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
102,408,940 | $5,900,803,122 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $312,376,808 | 5,959,115 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $331,056,442 | 5,998,486 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $306,633,535 | 6,252,723 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $285,803,405 | 6,621,951 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $257,826,163 | 6,714,223 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $270,133,942 | 6,972,998 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $237,588,645 | 7,025,093 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $277,081,410 | 6,777,921 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $261,887,780 | 6,802,280 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $298,330,229 | 6,958,951 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $261,383,809 | 7,052,990 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $255,853,913 | 7,058,039 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $258,200,858 | 7,244,693 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $264,377,652 | 7,430,513 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $260,785,887 | 7,421,340 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $222,683,890 | 7,566,561 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $363,217,054 | 8,507,405 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $384,295,112 | 8,994,904 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $389,624,508 | 9,007,976 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $340,249,256 | 9,079,035 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $357,876,742 | 9,163,297 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $328,130,834 | 9,373,894 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $343,261,066 | 9,510,345 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $346,662,124 | 9,390,232 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $372,748,694 | 9,317,126 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $339,033,596 | 9,123,000 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||